BioAI - Computer Vision + AI + Bio-sciences Organization that approaches cellular longevity as a data loss problem (ODIN.org)
Location: United States, California, Berkeley
Employees: 1-10
Mentions in press and media 7
| Date | Title | Description |
| 18.11.2024 | Conduktor Closes $30M Series B Funding | Conduktor, a NYC-based provider of an Enterprise Data Management (EDM) platform specialized in data streaming, raised $30M in Series B funding. The round was led by RTP Global, with participation from M12 (Microsoft’s venture fund), Ansa, a... |
| 27.04.2022 | Ansa Capital launches with $100M | New VC firm Ansa Capital has held a first close of $100 million for its debut fund, with limited partners including Princeton University, Henry Kravis and George Roberts. The fund will target investments of $5 million to $15 million in emer... |
| 11.08.2014 | The Road To Disrupt: A Look At Ansa, The Off-The-Record Messaging App | On this week’s installment of the Road To Disrupt video series, we meet our final Startup Battlefield company, Ansa. Built for more utility that that other ephemeral messaging service, Ansa enables users to to have more control over their t... |
| 20.10.2013 | Skim Is Snapchat For Text | Serious question: Which would you prefer? To have all of your chat conversations instantly deleted upon receipt (Snapchat-style), or to keep a record of each and every word forever on the Internet? A new app, Skim, is looking to answer that... |
| 09.09.2013 | Ansa Is A Messaging App That Lets You Talk Off The Record | Ansa is a new breed of messaging app, one that allows you to be yourself. Whenever you don’t feel like sending messages that will stay on your friend’s phone, you can go off the record. Every message will be deleted 60 seconds after reading... |
| 27.09.2000 | SNA to Integrate AVR into .NET | News SNA to Integrate AVR into .NET By Scott BekkerSeptember 27, 2000 Amalgamated Software of North America, Inc. (ASNA) has announced its intention to fully integrate its Visual RPG/Caviar (AVR) with Microsoft Visual Studio 7.0, a first st... |
| - | Startup Ansa Bio lands $68M to go long with enzymes approach to DNA synthesis | Genetic medicines R&D is making strides with more complex DNA molecules. While these long sequences of synthetic DNA are key for developing gene and cell therapies as well as antibodies and other biologic drugs, their length also poses ... |